These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 16160404)

  • 1. The Viscum album extract Iscador P does not cause an autocrine interleukin-6 loop in B-Non-Hodgkin's Lymphoma cell lines.
    Hugo F; Dittmar T; Treutler EK; Zänker KS; Kuehn JJ
    Onkologie; 2005 Aug; 28(8-9):415-20. PubMed ID: 16160404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytostatic and cytocidal effects of mistletoe (Viscum album L.) quercus extract Iscador.
    Kovacs E; Link S; Toffol-Schmidt U
    Arzneimittelforschung; 2006 Jun; 56(6A):467-73. PubMed ID: 16927528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of Viscum album QuFrF extract with vincristine in an in vitro model of human B cell lymphoma WSU-1.
    Kovacs E; Link S; Toffol-Schmidt U
    Arzneimittelforschung; 2008; 58(11):592-7. PubMed ID: 19137911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Measurements of IL-6, soluble IL-6 receptor and soluble gp130 in sera of B-cell lymphoma patients. Does viscum album treatment affect these parameters?
    Kovacs E; Kuehn JJ
    Biomed Pharmacother; 2002 May; 56(3):152-8. PubMed ID: 12046687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of Viscum album extract therapy in patients with cancer: relation with interleukin-6, soluble interleukin-6 receptor, and soluble gp130.
    Kovacs E
    J Altern Complement Med; 2004 Apr; 10(2):241-6. PubMed ID: 15165404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of mistletoe (Viscum album L.) extracts Iscador on cell cycle and survival of tumor cells.
    Harmsma M; Ummelen M; Dignef W; Tusenius KJ; Ramaekers FC
    Arzneimittelforschung; 2006 Jun; 56(6A):474-82. PubMed ID: 16927529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-CD20 antibody (IDEC-C2B8, rituximab) enhances efficacy of cytotoxic drugs on neoplastic lymphocytes in vitro: role of cytokines, complement, and caspases.
    Chow KU; Sommerlad WD; Boehrer S; Schneider B; Seipelt G; Rummel MJ; Hoelzer D; Mitrou PS; Weidmann E
    Haematologica; 2002 Jan; 87(1):33-43. PubMed ID: 11801463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Absence of tumor growth stimulation in a panel of 26 human tumor cell lines by mistletoe (Viscum album L.) extracts Iscador in vitro.
    Kelter G; Fiebig HH
    Arzneimittelforschung; 2006 Jun; 56(6A):435-40. PubMed ID: 16927523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigation of the effect of mistletoe (Viscum album L.) extract Iscador on the proliferation and apoptosis of murine thymocytes.
    Hajtò T; Berki T; Pàlinkàs L; Boldizsàr F; Németh P
    Arzneimittelforschung; 2006 Jun; 56(6A):441-6. PubMed ID: 16927524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene expression profiles of different breast cancer cells compared with their responsiveness to fermented mistletoe (Viscum album L.) extracts Iscador from oak (Quercus), pine (Pinus), white fir (Abies) and apple tree (Malus) in vitro.
    Eggenschwiler J; Patrignani A; Wagner U; Rehrauer H; Schlapbach R; Rist L; Ramos MH; Viviani A
    Arzneimittelforschung; 2006 Jun; 56(6A):483-96. PubMed ID: 16927530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular mechanisms underlying the immunomodulatory effects of mistletoe (Viscum album L.) extracts Iscador.
    Elluru S; Duong Van Huyen JP; Delignat S; Prost F; Bayry J; Kazatchkine MD; Kaveri SV
    Arzneimittelforschung; 2006 Jun; 56(6A):461-6. PubMed ID: 16927527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preclinical investigations with mistletoe (Viscum album L.) extract Iscador.
    Maldacker J
    Arzneimittelforschung; 2006 Jun; 56(6A):497-507. PubMed ID: 16927531
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiproliferative effects of mistletoe (Viscum album L.) extract in urinary bladder carcinoma cell lines.
    Urech K; Buessing A; Thalmann G; Schaefermeyer H; Heusser P
    Anticancer Res; 2006; 26(4B):3049-55. PubMed ID: 16886633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro activation of low-grade non-Hodgkin's lymphoma by murine fibroblasts, IL-4, anti-CD40 antibodies and the soluble CD40 ligand.
    Buske C; Twiling A; Gogowski G; Schreiber K; Feuring-Buske M; Wulf GG; Hiddemann W; Wörmann B
    Leukemia; 1997 Nov; 11(11):1862-7. PubMed ID: 9369419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nitric oxide involvement in the anti-tumor effect of mistletoe (Viscum album L.) extracts Iscador on human macrophages.
    Mossalayi MD; Alkharrat A; Malvy D
    Arzneimittelforschung; 2006 Jun; 56(6A):457-60. PubMed ID: 16927526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune modulation using mistletoe (Viscum album L.) extracts Iscador.
    Büssing A
    Arzneimittelforschung; 2006 Jun; 56(6A):508-15. PubMed ID: 16927532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of apoptosis of endothelial cells by Viscum album: a role for anti-tumoral properties of mistletoe lectins.
    Duong Van Huyen JP; Bayry J; Delignat S; Gaston AT; Michel O; Bruneval P; Kazatchkine MD; Nicoletti A; Kaveri SV
    Mol Med; 2002 Oct; 8(10):600-6. PubMed ID: 12477970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How does interleukin-6 affect the membrane expressions of interleukin-6 receptor and gp130 and the proliferation of the human myeloma cell line OPM-2?
    Kovacs E
    Biomed Pharmacother; 2003 Dec; 57(10):489-94. PubMed ID: 14637393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rituximab inactivates signal transducer and activation of transcription 3 (STAT3) activity in B-non-Hodgkin's lymphoma through inhibition of the interleukin 10 autocrine/paracrine loop and results in down-regulation of Bcl-2 and sensitization to cytotoxic drugs.
    Alas S; Bonavida B
    Cancer Res; 2001 Jul; 61(13):5137-44. PubMed ID: 11431352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin 3 is a growth factor for human follicular B cell lymphoma.
    Clayberger C; Luna-Fineman S; Lee JE; Pillai A; Campbell M; Levy R; Krensky AM
    J Exp Med; 1992 Feb; 175(2):371-6. PubMed ID: 1732410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.